4
Changes in Ownership
Dogwood Therapeutics, Inc. Filed Acc 0001415889-22-007076
Options or other derivatives
- CHIEF EXECUTIVE OFFICER acquired 90,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | 2022-06-23 | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | D | ||
Loading xslF345X03/form4-06302022_100647.xml…